Food News and Research

RSS

Novel antibacterial protein could prevent or treat E. coli O157:H7-induced food-borne infections

A novel antibacterial protein targeted against E. coli O157:H7 may offer a way to prevent or treat serious food-borne bacterial infections, as demonstrated in a study published in the December issue of Antimicrobial Agents and Chemotherapy.

21 Nov 2011

SAFC commences process validation activities for Oncolytics' REOLYSIN

Oncolytics Biotech Inc. today announced that SAFC, a Division of Sigma-Aldrich Corporation, has commenced validation activities designed to demonstrate the manufacturing process for the commercial production of REOLYSIN, Oncolytics' proprietary formulation of reovirus, is robust and reproducible.

21 Nov 2011

Princeton acquires Tru-D SmartUVC Room Decontamination System to improve patient care

In early September, Princeton Community Hospital added the Tru-D SmartUVC™ Room Decontamination System to its arsenal of new technology that helps disinfect environmental surfaces in patient rooms and in operating room suites.

21 Nov 2011

UTHealth and Memorial Hermann HVI first in Houston to implant FDA approved artificial heart valve

Cardiologists and cardiovascular surgeons at The University of Texas Health Science Center at Houston and Memorial Hermann Heart & Vascular Institute are the first in Houston to implant the artificial heart valve recently approved by the Food and Drug Administration, as well as a newer, smaller version that is part of a clinical trial.

21 Nov 2011

Impax initiates patent challenge related to Fentora

Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed in the Orange Book in connection with Fentora® (fentanyl buccal tablets, 100 mcg, 200 mcg, 400 mcg, 600 mcg and 800 mcg).

21 Nov 2011

Mylan settles Vivelle-Dot patent litigation lawsuit with Novartis

Mylan Inc. today announced that it has settled a patent litigation lawsuit with Novartis Pharmaceuticals Corporation related to Vivelle-Dot® (Estradiol Transdermal System USP, Twice-Weekly, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day and 0.075 mg/day and 0.1 mg/day).

21 Nov 2011

ZEVALIN treatment for Non-Hodgkin lymphoma becomes simpler with removal of bioscan requirement

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, received approval from the U.S. Food and Drug Administration (FDA) on November 18, 2011 to remove the pre-treatment biodistribution evaluation requirement using Indium-111 ZEVALIN imaging dose followed by a gamma scan before administering the ZEVALIN therapeutic dose.

21 Nov 2011

FDA grants HDE marketing approval for BSD-2000 Hyperthermia System to treat cervical cancer

BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company has obtained Humanitarian Device Exemption (HDE) marketing approval for the BSD-2000 Hyperthermia System (BSD-2000) from the U.S. Food and Drug Administration.

21 Nov 2011

ICON selected as CRO for Tasly's Dantonic pill global Phase III studies for chronic stable angina pectoris

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.

21 Nov 2011

Almac collaborates with Alexion for packaging and distribution of Soliris during German E. coli outbreak

Almac, a leading provider of contract services to the global pharmaceutical and biotech industries, responded earlier this year to an urgent request from their client partner, Alexion Pharmaceuticals, Inc., a global biotechnology company, for packaging and distribution of Soliris (eculizumab) for patients with STEC-HUS during the E. coli outbreak in Germany earlier this year.

21 Nov 2011

Avidocin protein could prevent or treat E. coli O157:H7-induced diarrhea

21 Nov 2011

Researchers discover more about function of muscle stem cells

An international team of researchers from Leeds, London and Berlin has discovered more about the function of muscle stem cells, thanks to next-generation DNA sequencing techniques.

20 Nov 2011

Omega-3 linked with reduced joint pain and cognitive side effects of breast cancer therapy

"I know I need this medicine to help lower my chance of cancer recurrence, but it makes my joints ache and stiff. It makes me feel old and I am not sure I can take this medication much longer."

19 Nov 2011

Millions of Afghans face hunger, disease after drought destroys crops

"Up to three million people in Afghanistan are facing hunger, malnutrition and disease after a severe drought wiped out their crops and extreme winter weather risks cutting off their access to vital food aid, a group of aid agencies warned Friday," Reuters reports.

19 Nov 2011

U.S., U.N. food agencies downgrade three Somalia famine zones to emergency status

U.S. and U.N. food agencies on Friday said three famine zones in Somalia had been downgraded to emergency status, as aid had reduced death rates, but "three other areas -- including the refugee communities of Somalia's capital, Mogadishu -- remain in the famine zone," the Associated Press/CBSNews reports.

19 Nov 2011

FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that the US Food and Drug Administration (FDA) has approved its orphan drug ERWINAZE (asparaginase Erwinia chrysanthemi) for the treatment of acute lymphoblastic leukemia (ALL) in patients with hypersensitivity to E. coli-derived asparaginase.

19 Nov 2011

FAMEDS founder condemns FDA decision on Avastin for metastatic breast cancer

Breast cancer patients, their families and advocates expressed extreme disappointment at today's Food and Drug Administration (FDA) decision to remove the anti-cancer drug Avastin from the approved medication list for treatment of late stage breast cancer.

19 Nov 2011

Food News and Research

Novel antibacterial protein could prevent or treat E. coli O157:H7-induced food-borne infections

SAFC commences process validation activities for Oncolytics' REOLYSIN

Princeton acquires Tru-D SmartUVC Room Decontamination System to improve patient care

UTHealth and Memorial Hermann HVI first in Houston to implant FDA approved artificial heart valve

Impax initiates patent challenge related to Fentora

Mylan settles Vivelle-Dot patent litigation lawsuit with Novartis

ZEVALIN treatment for Non-Hodgkin lymphoma becomes simpler with removal of bioscan requirement

FDA grants HDE marketing approval for BSD-2000 Hyperthermia System to treat cervical cancer

ICON selected as CRO for Tasly's Dantonic pill global Phase III studies for chronic stable angina pectoris

Almac collaborates with Alexion for packaging and distribution of Soliris during German E. coli outbreak

Avidocin protein could prevent or treat E. coli O157:H7-induced diarrhea

Researchers discover more about function of muscle stem cells

Omega-3 linked with reduced joint pain and cognitive side effects of breast cancer therapy

Millions of Afghans face hunger, disease after drought destroys crops

U.S., U.N. food agencies downgrade three Somalia famine zones to emergency status

FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia

FAMEDS founder condemns FDA decision on Avastin for metastatic breast cancer

New, incision-free surgery to manage chronic acid reflux

Celebrate World Toilet Day and help flush out poverty

A better handle for researchers to tackle Alzheimer's disease

Enhancing confidence in chemical ionization spectrometry data eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News